Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Parkinson's disease: in vivo metabolic changes in the frontal and parietal cortices in 6-OHDA treated rats during different periods.

Hou Z, Zhang Z, Meng H, Lin X, Sun B, Lei H, Fang K, Fang F, Liu M, Liu S.

Int J Neurosci. 2014 Feb;124(2):125-32. doi: 10.3109/00207454.2013.825616.

PMID:
23931110
2.

A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.

Taylor-Robinson SD, Turjanski N, Bhattacharya S, Seery JP, Sargentoni J, Brooks DJ, Bryant DJ, Cox IJ.

Metab Brain Dis. 1999 Mar;14(1):45-55.

PMID:
10348313
3.

Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.

Reneman L, Majoie CB, Flick H, den Heeten GJ.

AJNR Am J Neuroradiol. 2002 Feb;23(2):231-7.

4.

Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy.

Fu W, Zheng Z, Zhuang W, Chen D, Wang X, Sun X, Wang X.

Int J Neurosci. 2013 Dec;123(12):883-91. doi: 10.3109/00207454.2013.814132.

PMID:
23768098
5.

In vivo measurements of glutamine + glutamate (Glx) and N-acetyl aspartate (NAA) levels in human partial epilepsy.

Savic I, Thomas AM, Ke Y, Curran J, Fried I, Engel J Jr.

Acta Neurol Scand. 2000 Sep;102(3):179-88.

PMID:
10987378
6.

Effect of creatine supplementation on metabolite levels in ALS motor cortices.

Vielhaber S, Kaufmann J, Kanowski M, Sailer M, Feistner H, Tempelmann C, Elger CE, Heinze HJ, Kunz WS.

Exp Neurol. 2001 Dec;172(2):377-82.

PMID:
11716561
7.

Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.

Saksena S, Rai V, Saraswat VA, Rathore RS, Purwar A, Kumar M, Thomas MA, Gupta RK.

J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e111-9.

PMID:
17924951
8.

Proton spectroscopic imaging shows abnormalities in glial and neuronal cell pools in frontal lobe epilepsy.

Lundbom N, Gaily E, Vuori K, Paetau R, Liukkonen E, Rajapakse JC, Valanne L, Häkkinen AM, Granström ML.

Epilepsia. 2001 Dec;42(12):1507-14.

9.

Multivoxel MRS: right frontal parafalcine cortex - area of neurobiochemical gender differentiation?

Ostojic J, Kozic D, Lucic M, Konstantinovic J, Covickovic-Sternic N, Pavlovic A, Bogdanovic-Stojanovic D, Semnic R.

Neuro Endocrinol Lett. 2011;32(5):683-7.

PMID:
22167141
10.

Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study.

Block W, Bayer TA, Tepest R, Träber F, Rietschel M, Müller DJ, Schulze TG, Honer WG, Maier W, Schild HH, Falkai P.

Neurosci Lett. 2000 Aug 4;289(2):147-51.

PMID:
10904141
11.

Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.

Sahin I, Alkan A, Keskin L, Cikim A, Karakas HM, Firat AK, Sigirci A.

J Diabetes Complications. 2008 Jul-Aug;22(4):254-60. doi: 10.1016/j.jdiacomp.2007.03.007.

PMID:
18413166
12.

Developmental delay in children: assessment with proton MR spectroscopy.

Filippi CG, Uluğ AM, Deck MD, Zimmerman RD, Heier LA.

AJNR Am J Neuroradiol. 2002 May;23(5):882-8.

13.

Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.

Pohl C, Block W, Karitzky J, Träber F, Schmidt S, Grothe C, Lamerichs R, Schild H, Klockgether T.

Arch Neurol. 2001 May;58(5):729-35.

PMID:
11346367
14.

Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome.

Śmigielska-Kuzia J, Boćkowski L, Sobaniec W, Kułak W, Sendrowski K.

Pharmacol Rep. 2010 Nov-Dec;62(6):1070-7.

15.

Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease.

Zhou B, Yuan F, He Z, Tan C.

Brain Imaging Behav. 2014 Mar;8(1):97-101. doi: 10.1007/s11682-013-9251-2.

PMID:
23955491
16.

Developmental brain changes investigated with proton magnetic resonance spectroscopy.

Hashimoto T, Tayama M, Miyazaki M, Fujii E, Harada M, Miyoshi H, Tanouchi M, Kuroda Y.

Dev Med Child Neurol. 1995 May;37(5):398-405.

PMID:
7768339
17.

The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients.

Gonul AS, Kitis O, Ozan E, Akdeniz F, Eker C, Eker OD, Vahip S.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):120-5.

PMID:
16236417
18.

Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.

Garcia M, Huppertz HJ, Ziyeh S, Buechert M, Schumacher M, Mader I.

Epilepsia. 2009 Mar;50(3):486-92. doi: 10.1111/j.1528-1167.2008.01801.x.

19.
20.

Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.

Bittner DM, Heinze HJ, Kaufmann J.

J Alzheimers Dis. 2013;36(1):155-63. doi: 10.3233/JAD-120778.

PMID:
23579327
Items per page

Supplemental Content

Support Center